Immune thrombocytopenia following actinomycin-D therapy.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003609:Dactinomycin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000188:drug therapy; D009918:Orbital Neoplasms / Q000188:drug therapy; D010307:Parotid Neoplasms / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology; D009396:Wilms Tumor / Q000188:drug therapy
D003609:Dactinomycin; D011241:Prednisone